National and international developments in cancer, health and policy. Produced in collaboration with the Press Association unless otherwise stated.
The number of GP prescriptions for stop smoking aids in England has fallen by 75% in the last decade, according to new figures.
Children in England with high-risk neuroblastoma will now be offered a cancer drug that could extend their life.
A chemical dye that lights up brain tumours during surgery should be available to more NHS patients in England, according to NICE.
The prostate cancer drug abiraterone has been provisionally rejected as a first-line treatment on the NHS in England.
The lung cancer immunotherapy drug pembrolizumab has been made widely available on the NHS in England after a price deal was reached.